Benzinga | May 10, 2021 06:33AM EDT

Matinas BioPharma Hldgs Q1 EPS $(0.03), Inline, Sales $33.33K Beat $20.00K Estimate

Matinas BioPharma Hldgs (AMEX:MTNB) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $33.33 thousand which beat the analyst consensus estimate of $20.00 thousand by 66.65 percent.